Loading...

Barry Massie, MD

TitleProfessor
InstitutionUniversity of California San Francisco
DepartmentMedicine
AddressVAMC 203
San Francisco CA 94121
Phone415-750-2112
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency Cardiology

    Collapse Research 
    Collapse Research Activities and Funding
    General Clinical Research Center
    NIH/NCRR M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Packer M, McMurray JJV, Krum H, Kiowski W, Massie B, Caspi A, Pratt CM, Petrie MC, DeMets D, Kobrin I, Roux S, Swedberg K. Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials. JACC Heart Fail. 2017 May; 5(5):317-326. PMID: 28449795.
      View in: PubMed
    2. Biegus J, Hillege HL, Postmus D, Valente MA, Bloomfield DM, Cleland JG, Cotter G, Davison BA, Dittrich HC, Fiuzat M, Givertz MM, Massie B, Metra M, Teerlink JR, Voors AA, O'Connor CM, Ponikowski P. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. Eur J Heart Fail. 2016 07; 18(7):830-9. PMID: 27170455.
      View in: PubMed
    3. Davison BA, Metra M, Senger S, Edwards C, Milo O, Bloomfield DM, Cleland JG, Dittrich HC, Givertz MM, O'Connor CM, Massie B, Ponikowski P, Teerlink JR, Voors AA, Cotter G. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. Eur J Heart Fail. 2016 08; 18(8):1041-50. PMID: 27114058.
      View in: PubMed
    4. McMurray JJ, Krum H, Abraham WT, Dickstein K, Køber LV, Desai AS, Solomon SD, Greenlaw N, Ali MA, Chiang Y, Shao Q, Tarnesby G, Massie B. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure. N Engl J Med. 2016 Apr 21; 374(16):1521-32. PMID: 27043774.
      View in: PubMed
    5. Krum H, McMurray JJ, Abraham WT, Dickstein K, Køber L, Desai AS, Solomon SD, Chiang Y, Gimpelewicz C, Reimund B, Ali MA, Tarnesby G, Massie B. The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics. Eur J Heart Fail. 2015 Oct; 17(10):1075-83. PMID: 26511146.
      View in: PubMed
    6. Kao DP, Lewsey JD, Anand IS, Massie B, Zile MR, Carson PE, McKelvie RS, Komajda M, McMurray JJ, Lindenfeld J. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. Eur J Heart Fail. 2015 Sep; 17(9):925-35. PMID: 26250359; PMCID: PMC4654630.
    7. Heidenreich PA, Sahay A, Mittman BS, Oliva N, Gholami P, Rumsfeld JS, Massie B. Facilitation of a Multihospital Community of Practice to Increase Enrollment in the Hospital to Home National Quality Improvement Initiative. Jt Comm J Qual Patient Saf. 2015 Aug; 41(8):361-9. PMID: 26215525.
      View in: PubMed
    8. Carson PE, Anand IS, Win S, Rector T, Haass M, Lopez-Sendon J, Miller A, Teerlink JR, White M, McKelvie RS, Komajda M, Zile MR, McMurray JJ, Massie B. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). JACC Heart Fail. 2015 Jun; 3(6):429-441. PMID: 25982110.
      View in: PubMed
    9. Davison BA, Metra M, Cotter G, Massie B, Cleland JGF, Dittrich HC, Edwards C, Filippatos G, Givertz MM, Greenberg B, Ponikowski P, Voors AA, O'Connor CM, Teerlink JR. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies. JACC Heart Fail. 2015 May; 3(5):395-403. PMID: 25951761.
      View in: PubMed
    10. Cowie MR, Anker SD, Cleland JGF, Felker GM, Filippatos G, Jaarsma T, Jourdain P, Knight E, Massie B, Ponikowski P, López-Sendón J. Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Fail. 2014 Dec; 1(2):110-145. PMID: 28834628.
      View in: PubMed
    11. Metra M, Mentz RJ, Chiswell K, Bloomfield DM, Cleland JG, Cotter G, Davison BA, Dittrich HC, Fiuzat M, Givertz MM, Lazzarini V, Mansoor GA, Massie B, Ponikowski P, Teerlink JR, Voors AA, O'Connor CM. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial. Eur J Heart Fail. 2015 Jan; 17(1):109-18. PMID: 25431336.
      View in: PubMed
    12. Tang WH, Dupont M, Hernandez AF, Voors AA, Hsu AP, Felker GM, Butler J, Metra M, Anker SD, Troughton RW, Gottlieb SS, McMurray JJ, Armstrong PW, Massie B, Califf RM, O'Connor CM, Starling RC. Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial. JACC Heart Fail. 2015 Jan; 3(1):40-9. PMID: 25453534.
      View in: PubMed
    13. Adabag S, Rector TS, Anand IS, McMurray JJ, Zile M, Komajda M, McKelvie RS, Massie B, Carson PE. A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2014 Nov; 16(11):1175-82. PMID: 25302657.
      View in: PubMed
    14. Oluleye OW, Rector TS, Win S, McMurray JJ, Zile MR, Komajda M, McKelvie RS, Massie B, Carson PE, Anand IS. History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2014 Nov; 7(6):960-6. PMID: 25225241.
      View in: PubMed
    15. Böhm M, Perez AC, Jhund PS, Reil JC, Komajda M, Zile MR, McKelvie RS, Anand IS, Massie B, Carson PE, McMurray JJ. Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve). Eur J Heart Fail. 2014 Jul; 16(7):778-87. PMID: 24864045.
      View in: PubMed
    16. Mentz RJ, Cotter G, Cleland JG, Stevens SR, Chiswell K, Davison BA, Teerlink JR, Metra M, Voors AA, Grinfeld L, Ruda M, Mareev V, Lotan C, Bloomfield DM, Fiuzat M, Givertz MM, Ponikowski P, Massie B, O'Connor CM. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial. Eur J Heart Fail. 2014 Jun; 16(6):614-24. PMID: 24771609.
      View in: PubMed
    17. Kalogeropoulos AP, Tang WH, Hsu A, Felker GM, Hernandez AF, Troughton RW, Voors AA, Anker SD, Metra M, McMurray JJ, Massie B, Ezekowitz JA, Califf RM, O'Connor CM, Starling RC, Butler J. High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. J Card Fail. 2014 May; 20(5):319-26. PMID: 24530944.
      View in: PubMed
    18. Shalaby AA, Brumberg GE, Pointer L, Bekelman DB, Rumsfeld JS, Yang Y, Pellegrini CN, Heidenreich PA, Keung E, Massie B, Varosy PD. Depression and outcome among veterans with implantable cardioverter defibrillators with or without cardiac resynchronization therapy capability. Pacing Clin Electrophysiol. 2014 Aug; 37(8):994-1001. PMID: 24520992.
      View in: PubMed
    19. Toma M, Ezekowitz JA, Bakal JA, O'Connor CM, Hernandez AF, Sardar MR, Zolty R, Massie B, Swedberg K, Armstrong PW, Starling RC. The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial. Eur J Heart Fail. 2014 Mar; 16(3):334-41. PMID: 24464687.
      View in: PubMed
    20. Meyer S, van der Meer P, Massie B, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Cleland JG, Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL, Voors AA. Sex-specific acute heart failure phenotypes and outcomes from PROTECT. Eur J Heart Fail. 2013 Dec; 15(12):1374-81. PMID: 24259042.
      View in: PubMed
    21. Cleland JG, Chiswell K, Teerlink JR, Stevens S, Fiuzat M, Givertz MM, Davison BA, Mansoor GA, Ponikowski P, Voors AA, Cotter G, Metra M, Massie B, O'Connor CM. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study. Circ Heart Fail. 2014 Jan; 7(1):76-87. PMID: 24281134.
      View in: PubMed
    22. Givertz MM, Postmus D, Hillege HL, Mansoor GA, Massie B, Davison BA, Ponikowski P, Metra M, Teerlink JR, Cleland JG, Dittrich HC, O'Connor CM, Cotter G, Voors AA. Renal function trajectories and clinical outcomes in acute heart failure. Circ Heart Fail. 2014 Jan; 7(1):59-67. PMID: 24281137.
      View in: PubMed
    23. Heidenreich PA, Lin S, Knowles JW, Perez M, Maddox TM, Ho MP, Rumsfeld JS, Sahay A, Massie B, Tsai TT, Witteles RM. Variation in use of left ventriculography in the Veterans Affairs Health Care System. Circ Cardiovasc Qual Outcomes. 2013 Nov; 6(6):687-93. PMID: 24192569.
      View in: PubMed
    24. Gheorghiade M, Vaduganathan M, Fonarow GC, Greene SJ, Greenberg BH, Liu PP, Massie B, Mehra MR, Metra M, Zannad F, Cleland JG, van Veldhuisen DJ, Shah AN, Butler J. Anticoagulation in heart failure: current status and future direction. Heart Fail Rev. 2013 Nov; 18(6):797-813. PMID: 22987320.
      View in: PubMed
    25. Reed SD, Kaul P, Li Y, Eapen ZJ, Davidson-Ray L, Schulman KA, Massie B, Armstrong PW, Starling RC, O'Connor CM, Hernandez AF, Califf RM. Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: findings from ASCEND-HF. J Card Fail. 2013 Sep; 19(9):611-20. PMID: 24054337.
      View in: PubMed
    26. Homma S, Thompson JL, Sanford AR, Mann DL, Sacco RL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Mohr JP, Massie B, Labovitz AJ, Di Tullio MR, Gabriel AP, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD. Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial. Circ Heart Fail. 2013 Sep 01; 6(5):988-97. PMID: 23881846; PMCID: PMC4242511.
    27. Lesogor A, Cohn JN, Latini R, Tognoni G, Krum H, Massie B, Zalewski A, Kandra A, Hua TA, Gimpelewicz C. Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study. Eur J Heart Fail. 2013 Nov; 15(11):1236-44. PMID: 23787721.
      View in: PubMed
    28. Eapen ZJ, Reed SD, Li Y, Kociol RD, Armstrong PW, Starling RC, McMurray JJ, Massie B, Swedberg K, Ezekowitz JA, Fonarow GC, Teerlink JR, Metra M, Whellan DJ, O'Connor CM, Califf RM, Hernandez AF. Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF. Circ Heart Fail. 2013 Jul; 6(4):727-32. PMID: 23770519.
      View in: PubMed
    29. Milfred-LaForest SK, Chow SL, DiDomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL, Patterson JH, Vardeny O, Massie B. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. Pharmacotherapy. 2013 May; 33(5):529-48. PMID: 23649813.
      View in: PubMed
    30. Milfred-Laforest SK, Chow SL, Didomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL, Patterson JH, Vardeny O, Massie B. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. J Card Fail. 2013 May; 19(5):354-69. PMID: 23663818.
      View in: PubMed
    31. Packer M, Colucci W, Fisher L, Massie B, Teerlink JR, Young J, Padley RJ, Thakkar R, Delgado-Herrera L, Salon J, Garratt C, Huang B, Sarapohja T. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail. 2013 Apr; 1(2):103-11. PMID: 24621834.
      View in: PubMed
    32. van der Meer P, Postmus D, Ponikowski P, Cleland JG, O'Connor CM, Cotter G, Metra M, Davison BA, Givertz MM, Mansoor GA, Teerlink JR, Massie B, Hillege HL, Voors AA. The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol. 2013 May 14; 61(19):1973-81. PMID: 23500313.
      View in: PubMed
    33. Mentz RJ, Hernandez AF, Stebbins A, Ezekowitz JA, Felker GM, Heizer GM, Atar D, Teerlink JR, Califf RM, Massie B, Hasselblad V, Starling RC, O'Connor CM, Ponikowski P. Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF. Eur J Heart Fail. 2013 Apr; 15(4):456-64. PMID: 23159547; PMCID: PMC3605752.
    34. Lam CS, Carson PE, Anand IS, Rector TS, Kuskowski M, Komajda M, McKelvie RS, McMurray JJ, Zile MR, Massie B, Kitzman DW. Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail. 2012 Sep 01; 5(5):571-8. PMID: 22887722; PMCID: PMC4768740.
    35. Sung RK, Massie B, Varosy PD, Moore H, Rumsfeld J, Lee BK, Keung E. Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience. Heart Rhythm. 2012 Dec; 9(12):1954-61. PMID: 22871583.
      View in: PubMed
    36. Felker GM, Hasselblad V, Tang WH, Hernandez AF, Armstrong PW, Fonarow GC, Voors AA, Metra M, McMurray JJ, Butler J, Heizer GM, Dickstein K, Massie B, Atar D, Troughton RW, Anker SD, Califf RM, Starling RC, O'Connor CM. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. Eur J Heart Fail. 2012 Nov; 14(11):1257-64. PMID: 22764184.
      View in: PubMed
    37. Costanzo MR, Heywood JT, Massie B, Iwashita J, Henderson L, Mamatsashvili M, Sisakian H, Hayrapetyan H, Sager P, van Veldhuisen DJ, Albrecht D. A double-blind, randomized, parallel, placebo-controlled study examining the effect of cross-linked polyelectrolyte in heart failure patients with chronic kidney disease. Eur J Heart Fail. 2012 Aug; 14(8):922-30. PMID: 22613585.
      View in: PubMed
    38. Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie B, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012 May 17; 366(20):1859-69. PMID: 22551105; PMCID: PMC3723382.
    39. O'Connor CM, Mentz RJ, Cotter G, Metra M, Cleland JG, Davison BA, Givertz MM, Mansoor GA, Ponikowski P, Teerlink JR, Voors AA, Fiuzat M, Wojdyla D, Chiswell K, Massie B. The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction. Eur J Heart Fail. 2012 Jun; 14(6):605-12. PMID: 22535795.
      View in: PubMed
    40. McMurray JJ, Abraham WT, Dickstein K, Køber L, Massie B, Krum H. Aliskiren, ALTITUDE, and the implications for ATMOSPHERE. Eur J Heart Fail. 2012 Apr; 14(4):341-3. PMID: 22431404; PMCID: PMC3307357.
    41. Teerlink JR, Iragui VJ, Mohr JP, Carson PE, Hauptman PJ, Lovett DH, Miller AB, Piña IL, Thomson S, Varosy PD, Zile MR, Cleland JG, Givertz MM, Metra M, Ponikowski P, Voors AA, Davison BA, Cotter G, Wolko D, Delucca P, Salerno CM, Mansoor GA, Dittrich H, O'Connor CM, Massie B. The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT. Drug Saf. 2012 Mar 01; 35(3):233-44. PMID: 22339573.
      View in: PubMed
    42. Greenberg BH, Anand IS, Burnett JC, Chin J, Dracup KA, Feldman AM, Force T, Francis GS, Houser SR, Hunt SA, Konstam MA, Lindenfeld J, Mann DL, Mehra MR, Paul SC, Piano MR, Ross HJ, Sabbah HN, Starling RC, Udelson JE, Yancy CW, Zile MR, Massie B. The Heart Failure Society of America in 2020: a vision for the future. J Card Fail. 2012 Feb; 18(2):90-3. PMID: 22300775.
      View in: PubMed
    43. Rector TS, Carson PE, Anand IS, McMurray JJ, Zile MR, McKelvie RS, Komajda M, Kuskowski M, Massie B. Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial. Circ Heart Fail. 2012 Mar 01; 5(2):217-25. PMID: 22267751.
      View in: PubMed
    44. Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie B, Carson PE. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011 Dec 06; 124(23):2491-501. PMID: 22064591.
      View in: PubMed
    45. Piller LB, Baraniuk S, Simpson LM, Cushman WC, Massie B, Einhorn PT, Oparil S, Ford CE, Graumlich JF, Dart RA, Parish DC, Retta TM, Cuyjet AB, Jafri SZ, Furberg CD, Saklayen MG, Thadani U, Probstfield JL, Davis BR. Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Circulation. 2011 Oct 25; 124(17):1811-8. PMID: 21969009; PMCID: PMC3217334.
    46. O'Connor CM, Fiuzat M, Lombardi C, Fujita K, Jia G, Davison BA, Cleland J, Bloomfield D, Dittrich HC, Delucca P, Givertz MM, Mansoor G, Ponikowski P, Teerlink JR, Voors AA, Massie B, Cotter G, Metra M. Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. Circ Heart Fail. 2011 Nov; 4(6):724-32. PMID: 21900185.
      View in: PubMed
    47. Massie B. Globalization of clinical trials how should we interpret differences in outcomes? J Am Coll Cardiol. 2011 Aug 23; 58(9):923-4. PMID: 21851880.
      View in: PubMed
    48. Krum H, Elsik M, Schneider HG, Ptaszynska A, Black M, Carson PE, Komajda M, Massie B, McKelvie RS, McMurray JJ, Zile MR, Anand IS. Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy. Circ Heart Fail. 2011 Sep; 4(5):561-8. PMID: 21750125.
      View in: PubMed
    49. Anand IS, Rector TS, Cleland JG, Kuskowski M, McKelvie RS, Persson H, McMurray JJ, Zile MR, Komajda M, Massie B, Carson PE. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. Circ Heart Fail. 2011 Sep; 4(5):569-77. PMID: 21715583.
      View in: PubMed
    50. Steinman MA, Harlow JB, Massie B, Kaboli PJ, Fung KZ, Heidenreich PA. Age and receipt of guideline-recommended medications for heart failure: a nationwide study of veterans. J Gen Intern Med. 2011 Oct; 26(10):1152-9. PMID: 21604076; PMCID: PMC3181303.
    51. Voors AA, Dittrich HC, Massie B, DeLucca P, Mansoor GA, Metra M, Cotter G, Weatherley BD, Ponikowski P, Teerlink JR, Cleland JG, O'Connor CM, Givertz MM. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). J Am Coll Cardiol. 2011 May 10; 57(19):1899-907. PMID: 21545947.
      View in: PubMed
    52. Jessup M, Albert NM, Lanfear DE, Lindenfeld J, Massie B, Walsh MN, Zucker MJ. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation. J Card Fail. 2011 May; 17(5):349-58. PMID: 21549290.
      View in: PubMed
    53. Massie B. Novel targets for the treatment of heart failure: perspectives from a heart failure clinician and trialist. J Mol Cell Cardiol. 2011 Oct; 51(4):438-40. PMID: 21549124.
      View in: PubMed
    54. Jessup M, Albert NM, Lanfear DE, Lindenfeld J, Massie B, Walsh MN, Zucker MJ. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America. J Am Coll Cardiol. 2011 May 17; 57(20):2115-24. PMID: 21470814.
      View in: PubMed
    55. Jessup M, Albert NM, Lanfear DE, Lindenfeld J, Massie B, Walsh MN, Zucker MJ. ACCF/AHA/HFSA 2011 survey results: current staffing profile of heart failure programs, including programs that perform heart transplant and mechanical circulatory support device implantation: a report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America. Circ Heart Fail. 2011 May; 4(3):378-87. PMID: 21464151.
      View in: PubMed
    56. Metra M, O'Connor CM, Davison BA, Cleland JG, Ponikowski P, Teerlink JR, Voors AA, Givertz MM, Mansoor GA, Bloomfield DM, Jia G, DeLucca P, Massie B, Dittrich H, Cotter G. Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. Eur Heart J. 2011 Jun; 32(12):1519-34. PMID: 21388992.
      View in: PubMed
    57. Ghali JK, Massie B, Mann DL, Rich MW. Guidelines are merely guidelines. J Card Fail. 2011 Mar; 17(3):208-9. PMID: 21362528.
      View in: PubMed
    58. Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie B, Carson PE. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail. 2011 May; 4(3):324-31. PMID: 21350053; PMCID: PMC3100162.
    59. Ghali JK, Massie B, Mann DL, Rich MW. Heart failure guidelines, performance measures, and the practice of medicine: mind the gap. J Card Fail. 2011 Jan; 17(1):90.e1-4. PMID: 21229805.
      View in: PubMed
    60. Krum H, Massie B, Abraham WT, Dickstein K, Kober L, McMurray JJ, Desai A, Gimpelewicz C, Kandra A, Reimund B, Rattunde H, Armbrecht J. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study. Eur J Heart Fail. 2011 Jan; 13(1):107-14. PMID: 21169387.
      View in: PubMed
    61. Ghali JK, Massie B, Mann DL, Rich MW. Heart failure guidelines, performance measures, and the practice of medicine: mind the gap. J Am Coll Cardiol. 2010 Dec 14; 56(25):2077-80. PMID: 21144966.
      View in: PubMed
    62. Ghali JK, Massie B, Mann DL, Rich MW. Guidelines, performance measures, and the practice of medicine: mind the gap. J Card Fail. 2010 Dec; 16(12):915-8. PMID: 21111978.
      View in: PubMed
    63. Komajda M, Carson PE, Hetzel S, McKelvie R, McMurray J, Ptaszynska A, Zile MR, Demets D, Massie B. Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). Circ Heart Fail. 2011 Jan; 4(1):27-35. PMID: 21068341.
      View in: PubMed
    64. Massie B, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med. 2010 Oct 07; 363(15):1419-28. PMID: 20925544.
      View in: PubMed
    65. Ponikowski P, Mitrovic V, O'Connor CM, Dittrich H, Cotter G, Massie B, Givertz MM, Chen E, Murray M, Weatherley BD, Fujita KP, Metra M. Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function. Eur J Heart Fail. 2010 Nov; 12(11):1238-46. PMID: 20823097.
      View in: PubMed
    66. Peacock WF, Braunwald E, Abraham W, Albert N, Burnett J, Christenson R, Collins S, Diercks D, Fonarow G, Hollander J, Kellerman A, Gheorghiade M, Kirk D, Levy P, Maisel A, Massie B, O'Connor C, Pang P, Shah M, Sopko G, Stevenson L, Storrow A, Teerlink J. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. J Am Coll Cardiol. 2010 Jul 27; 56(5):343-51. PMID: 20650354.
      View in: PubMed
    67. Heidenreich PA, Sahay A, Kapoor JR, Pham MX, Massie B. Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs health care system 2002 to 2006. J Am Coll Cardiol. 2010 Jul 27; 56(5):362-8. PMID: 20650356.
      View in: PubMed
    68. Massie B. Is the effect of angiotensin receptor blockade in patients with heart failure modified by treatment with aspirin? The answer is not so clear! Eur J Heart Fail. 2010 Jul; 12(7):639-41. PMID: 20576831.
      View in: PubMed
    69. Gottlieb SS, Givertz MM, Metra M, Gergich K, Bird S, Jones-Burton C, Massie B, Cotter G, Ponikowski P, Weatherley B, O'Connor C, Dittrich H. The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study. J Card Fail. 2010 Sep; 16(9):714-9. PMID: 20797594.
      View in: PubMed
    70. McCullough PA, Haapio M, Mankad S, Zamperetti N, Massie B, Bellomo R, Berl T, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bobek I, Cruz DN, Daliento L, Davenport A, Hillege H, House AA, Katz N, Maisel A, Mebazaa A, Palazzuoli A, Ponikowski P, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zanco P, Ronco C, Berl T. Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant. 2010 Jun; 25(6):1777-84. PMID: 20375030.
      View in: PubMed
    71. Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB, Lopez-Sendon J, Teerlink JR, White M, McMurray JJ, Komajda M, McKelvie R, Ptaszynska A, Hetzel SJ, Massie B, Carson PE. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation. 2010 Mar 30; 121(12):1393-405. PMID: 20231531.
      View in: PubMed
    72. Metra M, Cleland JG, Weatherley BD, Dittrich HC, Givertz MM, Massie B, O'Connor CM, Ponikowski P, Teerlink JR, Voors AA, Cotter G. Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study. Eur J Heart Fail. 2010 May; 12(5):499-507. PMID: 20228387.
      View in: PubMed
    73. Felker GM, Pang PS, Adams KF, Cleland JG, Cotter G, Dickstein K, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie B, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pina IL, Ponikowski P, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Gheorghiade M. Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. Circ Heart Fail. 2010 Mar; 3(2):314-25. PMID: 20233993.
      View in: PubMed
    74. Massie B. The Journal of Cardiac Failure: passing the baton. J Card Fail. 2010 Jan; 16(1):1. PMID: 20123311.
      View in: PubMed
    75. Weatherley BD, Cotter G, Dittrich HC, DeLucca P, Mansoor GA, Bloomfield DM, Ponikowski P, O'Connor CM, Metra M, Massie B. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function. J Card Fail. 2010 Jan; 16(1):25-35. PMID: 20123315.
      View in: PubMed
    76. Haywood LJ, Ford CE, Crow RS, Davis BR, Massie B, Einhorn PT, Williard A. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). J Am Coll Cardiol. 2009 Nov 24; 54(22):2023-31. PMID: 19926008.
      View in: PubMed
    77. McKelvie RS, Komajda M, McMurray J, Zile M, Ptaszynska A, Donovan M, Carson P, Massie B. Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial. J Card Fail. 2010 Feb; 16(2):128-34. PMID: 20142024.
      View in: PubMed
    78. Cotter G, Metra M, Weatherley BD, Dittrich HC, Massie B, Ponikowski P, Bloomfield DM, O'Connor CM. Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes. Cardiology. 2010; 115(1):29-36. PMID: 19844102.
      View in: PubMed
    79. Massie B. Prevention of heart failure with chlorthalidone in ALLHAT: placing the results into perspective. J Clin Hypertens (Greenwich). 2009 Sep; 11(9):462-5. PMID: 19751457.
      View in: PubMed
    80. Patterson ME, Grant WC, Glickman SW, Massie B, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Teo KK, Schulman KA, Reed SD. Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation. J Card Fail. 2009 Dec; 15(10):819-27. PMID: 19944357.
      View in: PubMed
    81. Gheorghiade M, Adams KF, Cleland JG, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie B, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Piña IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J. 2009 Jun; 157(6):957-70. PMID: 19464405.
      View in: PubMed
    82. Massie B, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, Jafri SM, Krol WF, O'Connor CM, Schulman KA, Teo K, Warren SR. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation. 2009 Mar 31; 119(12):1616-24. PMID: 19289640.
      View in: PubMed
    83. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A, Calkins H, Connolly SJ, Curtis AB, Darbar D, Ellinor PT, Go AS, Goldschlager NF, Heckbert SR, Jalife J, Kerr CR, Levy D, Lloyd-Jones DM, Massie B, Nattel S, Olgin JE, Packer DL, Po SS, Tsang TS, Van Wagoner DR, Waldo AL, Wyse DG. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation. 2009 Feb 03; 119(4):606-18. PMID: 19188521.
      View in: PubMed
    84. Metra M, Dei Cas L, Massie B. Treatment of heart failure in the elderly: never say it's too late. Eur Heart J. 2009 Feb; 30(4):391-3. PMID: 19181708.
      View in: PubMed
    85. Hernandez AF, O'Connor CM, Starling RC, Reist CJ, Armstrong PW, Dickstein K, Lorenz TJ, Gibler WB, Hasselblad V, Komajda M, Massie B, McMurray JJ, Nieminen M, Rouleau JL, Swedberg K, Califf RM. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). Am Heart J. 2009 Feb; 157(2):271-7. PMID: 19185633.
      View in: PubMed
    86. Ezekowitz JA, Hernandez AF, Starling RC, Yancy CW, Massie B, Hill JA, Krum H, Diaz R, Ponikowski P, Metra M, Howlett JG, Gennevois D, O'Connor CM, Califf RM, Fonarow GC. Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF). Am Heart J. 2009 Feb; 157(2):219-28. PMID: 19185628.
      View in: PubMed
    87. Massie B, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008 Dec 04; 359(23):2456-67. PMID: 19001508.
      View in: PubMed
    88. Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, Farber MA, Ford CE, Levy D, Massie B, Nawaz S. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Circulation. 2008 Nov 25; 118(22):2259-67. PMID: 19001024; PMCID: PMC2775475.
    89. Cotter G, Dittrich HC, Weatherley BD, Bloomfield DM, O'Connor CM, Metra M, Massie B. The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J Card Fail. 2008 Oct; 14(8):631-40. PMID: 18926433.
      View in: PubMed
    90. Yancy CW, Krum H, Massie B, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial. Circ Heart Fail. 2008 May; 1(1):9-16. PMID: 19808265.
      View in: PubMed
    91. Klein L, Massie B, Leimberger JD, O'Connor CM, Piña IL, Adams KF, Califf RM, Gheorghiade M. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail. 2008 May; 1(1):25-33. PMID: 19808267.
      View in: PubMed
    92. Pang PS, Cleland JG, Teerlink JR, Collins SP, Lindsell CJ, Sopko G, Peacock WF, Fonarow GC, Aldeen AZ, Kirk JD, Storrow AB, Tavares M, Mebazaa A, Roland E, Massie B, Maisel AS, Komajda M, Filippatos G, Gheorghiade M. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J. 2008 Mar; 29(6):816-24. PMID: 18310669.
      View in: PubMed
    93. Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, Fontanella B, Lombardi C, Milani P, Verzura G, Cotter G, Dittrich H, Massie B, Dei Cas L. Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail. 2008 Feb; 10(2):188-95. PMID: 18279773.
      View in: PubMed
    94. McMurray JJ, Carson PE, Komajda M, McKelvie R, Zile MR, Ptaszynska A, Staiger C, Donovan JM, Massie B. Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail. 2008 Feb; 10(2):149-56. PMID: 18279770.
      View in: PubMed
    95. Ghali JK, Anand IS, Abraham WT, Fonarow GC, Greenberg B, Krum H, Massie B, Wasserman SM, Trotman ML, Sun Y, Knusel B, Armstrong P. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation. 2008 Jan 29; 117(4):526-35. PMID: 18195176.
      View in: PubMed
    96. Givertz MM, Massie B, Fields TK, Pearson LL, Dittrich HC. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol. 2007 Oct 16; 50(16):1551-60. PMID: 17936154.
      View in: PubMed
    97. Chatterjee K, Massie B. Systolic and diastolic heart failure: differences and similarities. J Card Fail. 2007 Sep; 13(7):569-76. PMID: 17826648.
      View in: PubMed
    98. Massie B. Review: Available evidence does not support the use of beta blockers as first line treatment for hypertension. Evid Based Med. 2007 Aug; 12(4):112. PMID: 17885160.
      View in: PubMed
    99. Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie B, Zhu Y, Ticho B, Abraham WT. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. J Am Coll Cardiol. 2007 Aug 14; 50(7):600-6. PMID: 17692744.
      View in: PubMed
    100. Fowler MB, Lottes SR, Nelson JJ, Lukas MA, Gilbert EM, Greenberg B, Massie B, Abraham WT, Franciosa JA. Beta-blocker dosing in community-based treatment of heart failure. Am Heart J. 2007 Jun; 153(6):1029-36. PMID: 17540206.
      View in: PubMed
    101. Heidenreich PA, Gholami P, Sahay A, Massie B, Goldstein MK. Clinical reminders attached to echocardiography reports of patients with reduced left ventricular ejection fraction increase use of beta-blockers: a randomized trial. Circulation. 2007 Jun 05; 115(22):2829-34. PMID: 17515459.
      View in: PubMed
    102. Yancy CW, Krum H, Massie B, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R. The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design. Am Heart J. 2007 Apr; 153(4):478-84. PMID: 17383282.
      View in: PubMed
    103. Massie B, Nelson JJ, Lukas MA, Greenberg B, Fowler MB, Gilbert EM, Abraham WT, Lottes SR, Franciosa JA. Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice. Am J Cardiol. 2007 May 01; 99(9):1263-8. PMID: 17478155.
      View in: PubMed
    104. Marcus GM, Cohen J, Varosy PD, Vessey J, Rose E, Massie B, Chatterjee K, Waters D. The utility of gestures in patients with chest discomfort. Am J Med. 2007 Jan; 120(1):83-9. PMID: 17208083.
      View in: PubMed
    105. Abraham WT, Massie B, Lukas MA, Lottes SR, Nelson JJ, Fowler MB, Greenberg B, Gilbert EM, Franciosa JA. Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry. Congest Heart Fail. 2007 Jan-Feb; 13(1):16-21. PMID: 17268206.
      View in: PubMed
    106. Einhorn PT, Davis BR, Massie B, Cushman WC, Piller LB, Simpson LM, Levy D, Nwachuku CE, Black HR. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis. Am Heart J. 2007 Jan; 153(1):42-53. PMID: 17174636.
      View in: PubMed
    107. Weber MA, Bakris GL, Dahlöf B, Pitt B, Velazquez E, Gupte J, Lefkowitz M, Hester A, Shi V, Weir M, Kjeldsen S, Massie B, Nesbitt S, Ofili E, Jamerson K. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk. Blood Press. 2007; 16(1):13-9. PMID: 17453747.
      View in: PubMed
    108. Franciosa JA, Nelson JJ, Lukas MA, Lottes SR, Massie B, Fowler MB, Greenberg B, Gilbert EM, Abraham WT. Heart failure in community practice: relationship to age and sex in a beta-blocker registry. Congest Heart Fail. 2006 Nov-Dec; 12(6):317-23. PMID: 17170585.
      View in: PubMed
    109. Greenberg B, Lottes SR, Nelson JJ, Lukas MA, Fowler MB, Massie B, Abraham WT, Gilbert EM, Franciosa JA. Predictors of clinical outcomes in patients given carvedilol for heart failure. Am J Cardiol. 2006 Dec 01; 98(11):1480-4. PMID: 17126654.
      View in: PubMed
    110. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie B, Shlipak MG. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation. 2006 Jun 13; 113(23):2713-23. PMID: 16754803.
      View in: PubMed
    111. Packer M, Abraham WT, Mehra MR, Yancy CW, Lawless CE, Mitchell JE, Smart FW, Bijou R, O'Connor CM, Massie B, Pina IL, Greenberg BH, Young JB, Fishbein DP, Hauptman PJ, Bourge RC, Strobeck JE, Murali S, Schocken D, Teerlink JR, Levy WC, Trupp RJ, Silver MA. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol. 2006 Jun 06; 47(11):2245-52. PMID: 16750691.
      View in: PubMed
    112. Quiñones MA, Zile MR, Massie B, Kass DA. Chronic heart failure: a report from the Dartmouth Diastole Discourses. Congest Heart Fail. 2006 May-Jun; 12(3):162-5. PMID: 16760702.
      View in: PubMed
    113. De Luca L, Colucci WS, Nieminen MS, Massie B, Gheorghiade M. Evidence-based use of levosimendan in different clinical settings. Eur Heart J. 2006 Aug; 27(16):1908-20. PMID: 16682381.
      View in: PubMed
    114. Massie B, Force T. The year in heart failure 2005. J Card Fail. 2006 Feb; 12(1):1-9. PMID: 16500577.
      View in: PubMed
    115. Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie B, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005 Dec 20; 112(25):3958-68. PMID: 16365214.
      View in: PubMed
    116. Carson P, Massie B, McKelvie R, McMurray J, Komajda M, Zile M, Ptaszynska A, Frangin G. The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design. J Card Fail. 2005 Oct; 11(8):576-85. PMID: 16230259.
      View in: PubMed
    117. Massie B. Aspirin use in chronic heart failure: what should we recommend to the practitioner? J Am Coll Cardiol. 2005 Sep 20; 46(6):963-6. PMID: 16168276.
      View in: PubMed
    118. Freudenberger RS, Massie B. Silent cerebral infarction in heart failure: vascular or thromboembolic? J Card Fail. 2005 Sep; 11(7):490-1. PMID: 16198242.
      View in: PubMed
    119. Massie B, Fabi MR. Clinical trials in diastolic heart failure. Prog Cardiovasc Dis. 2005 May-Jun; 47(6):389-95. PMID: 16115518.
      View in: PubMed
    120. Massie B. Heart failure trials: are they becoming impractical? J Card Fail. 2005 Apr; 11(3):161-3. PMID: 15812741.
      View in: PubMed
    121. Teerlink JR, Massie B. Nesiritide and worsening of renal function: the emperor's new clothes? Circulation. 2005 Mar 29; 111(12):1459-61. PMID: 15795361.
      View in: PubMed
    122. Massie B. Isosorbide dinitrate plus hydralazine was effective for advanced heart failure in black patients. ACP J Club. 2005 Mar-Apr; 142(2):37. PMID: 15739984.
      View in: PubMed
    123. Massie B. The year in heart failure: 2004. J Card Fail. 2005 Feb; 11(1):1-6. PMID: 15704055.
      View in: PubMed
    124. Packer M, McMurray J, Massie B, Caspi A, Charlon V, Cohen-Solal A, Kiowski W, Kostuk W, Krum H, Levine B, Rizzon P, Soler J, Swedberg K, Anderson S, Demets DL. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. J Card Fail. 2005 Feb; 11(1):12-20. PMID: 15704058.
      View in: PubMed
    125. Felker GM, Leimberger JD, Califf RM, Cuffe MS, Massie B, Adams KF, Gheorghiade M, O'Connor CM. Risk stratification after hospitalization for decompensated heart failure. J Card Fail. 2004 Dec; 10(6):460-6. PMID: 15599835.
      View in: PubMed
    126. Franciosa JA, Massie B, Lukas MA, Nelson JJ, Lottes S, Abraham WT, Fowler M, Gilbert EM, Greenberg B. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry. Am Heart J. 2004 Oct; 148(4):718-26. PMID: 15459606.
      View in: PubMed
    127. Massie B. Should the management of heart failure become a new subspecialty? J Card Fail. 2004 Oct; 10(5):363-5. PMID: 15470643.
      View in: PubMed
    128. Shlipak MG, Massie B. The clinical challenge of cardiorenal syndrome. Circulation. 2004 Sep 21; 110(12):1514-7. PMID: 15381655.
      View in: PubMed
    129. Hlatky MA, Massie B. Cardiac resynchronization for heart failure. Ann Intern Med. 2004 Sep 07; 141(5):399-400. PMID: 15313731.
      View in: PubMed
    130. Shlipak MG, Smith GL, Rathore SS, Massie B, Krumholz HM. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial. J Am Soc Nephrol. 2004 Aug; 15(8):2195-203. PMID: 15284305.
      View in: PubMed
    131. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study. Am J Med. 2004 Apr 15; 116(8):509-16. PMID: 15063811; PMCID: PMC2776680.
    132. Massie B, Krol WF, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Ezekowitz M, Jafri SM, O'Connor CM, Packer M, Schulman KA, Teo K, Warren S. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail. 2004 Apr; 10(2):101-12. PMID: 15101020.
      View in: PubMed
    133. Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie B, O'Connor CM, Rich MW, Stevenson LW, Wang Y, Young JB, Krumholz HM. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004 Feb; 147(2):331-8. PMID: 14760333.
      View in: PubMed
    134. Massie B. 2003: The year in heart failure. J Card Fail. 2004 Feb; 10(1):1-3. PMID: 14966766.
      View in: PubMed
    135. Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, Loh E, Massie B, Rich MW, Stevenson LW, Young JB, Krumholz HM. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004 Jan 07; 43(1):61-7. PMID: 14715185.
      View in: PubMed
    136. DeMets DL, Fleming TR, Rockhold F, Massie B, Merchant T, Meisel A, Mishkin B, Wittes J, Stump D, Califf R. Liability issues for data monitoring committee members. Clin Trials. 2004; 1(6):525-31. PMID: 16279293.
      View in: PubMed
    137. Ansari M, Araoz PA, Gerard SK, Watzinger N, Lund GK, Massie B, Higgins CB, Saloner DA. Comparison of late enhancement cardiovascular magnetic resonance and thallium SPECT in patients with coronary disease and left ventricular dysfunction. J Cardiovasc Magn Reson. 2004; 6(2):549-56. PMID: 15137339.
      View in: PubMed
    138. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation. 2003 Dec 16; 108(24):2987-92. PMID: 14662720; PMCID: PMC2771188.
    139. Massie B. A comment on COMET: how to interpret a positive trial? J Card Fail. 2003 Dec; 9(6):425-8. PMID: 14966781.
      View in: PubMed
    140. Massie B. The dilemma of drug development for heart failure: when is the time to initiate large clinical trials? J Card Fail. 2003 Oct; 9(5):347-9. PMID: 14583893.
      View in: PubMed
    141. Domanski MJ, Krause-Steinrauf H, Massie B, Deedwania P, Follmann D, Kovar D, Murray D, Oren R, Rosenberg Y, Young J, Zile M, Eichhorn E. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail. 2003 Oct; 9(5):354-63. PMID: 14583895.
      View in: PubMed
    142. Anderson JL, Krause-Steinrauf H, Goldman S, Clemson BS, Domanski MJ, Hager WD, Murray DR, Mann DL, Massie B, McNamara DM, Oren R, Rogers WJ. Failure of benefit and early hazard of bucindolol for Class IV heart failure. J Card Fail. 2003 Aug; 9(4):266-77. PMID: 13680547.
      View in: PubMed
    143. Havranek EP, Krumholz HM, Dudley RA, Adams K, Gregory D, Lampert S, Lindenfeld J, Massie B, Pina I, Restaino S, Rich MW, Konstam MA. Aligning quality and payment for heart failure care: defining the challenges. J Card Fail. 2003 Aug; 9(4):251-4. PMID: 13680543.
      View in: PubMed
    144. Ansari M, Massie B. Heart failure: how big is the problem? Who are the patients? What does the future hold? Am Heart J. 2003 Jul; 146(1):1-4. PMID: 12851600.
      View in: PubMed
    145. Ansari M, Alexander M, Tutar A, Massie B. Incident cases of heart failure in a community cohort: importance and outcomes of patients with preserved systolic function. Am Heart J. 2003 Jul; 146(1):115-20. PMID: 12851618.
      View in: PubMed
    146. Massie B. Natriuretic peptide measurements for the diagnosis of "nonsystolic" heart failure: good news and bad. J Am Coll Cardiol. 2003 Jun 04; 41(11):2018-21. PMID: 12798575.
      View in: PubMed
    147. Teerlink JR, Massie B. Late breaking heart failure trials from the 2003 ACC meeting: EPHESUS and COMPANION. J Card Fail. 2003 Jun; 9(3):158-63. PMID: 12815564.
      View in: PubMed
    148. Ansari M, Shlipak MG, Heidenreich PA, Van Ostaeyen D, Pohl EC, Browner WS, Massie B. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation. 2003 Jun 10; 107(22):2799-804. PMID: 12756157.
      View in: PubMed
    149. Massie B. Negative, neutral, and discordant results: what should an editor do? J Card Fail. 2003 Apr; 9(2):77-9. PMID: 12751126.
      View in: PubMed
    150. Jain P, Massie B, Gattis WA, Klein L, Gheorghiade M. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. Am Heart J. 2003 Feb; 145(2 Suppl):S3-17. PMID: 12594447.
      View in: PubMed
    151. Shlipak MG, Chertow GC, Massie B. Beware the rising creatinine level. J Card Fail. 2003 Feb; 9(1):26-8. PMID: 12612869.
      View in: PubMed
    152. Massie B, Ansari MN. Specialty care for heart failure: does it improve outcomes? Am Heart J. 2003 Feb; 145(2):209-13. PMID: 12595835.
      View in: PubMed
    153. Ansari M, Alexander M, Tutar A, Bello D, Massie B. Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting. J Am Coll Cardiol. 2003 Jan 01; 41(1):62-8. PMID: 12570946.
      View in: PubMed
    154. Massie B. What is the significance of a journal's impact factor? J Card Fail. 2002 Dec; 8(6):363-4. PMID: 12528086.
      View in: PubMed
    155. Massie B. What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physicians. J Card Fail. 2002 Aug; 8(4):197-201. PMID: 12397565.
      View in: PubMed
    156. Massie B. Obesity and heart failure--risk factor or mechanism? N Engl J Med. 2002 Aug 01; 347(5):358-9. PMID: 12151474.
      View in: PubMed
    157. Massie B. Treating heart failure: it's time for new paradigms and novel approaches. J Card Fail. 2002 Jun; 8(3):117-9. PMID: 12140801.
      View in: PubMed
    158. Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie B, O'connor CM, Rich MW, Stevenson LW, Young J, Krumholz HM. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002 Jun; 8(3):136-41. PMID: 12140805.
      View in: PubMed
    159. Massie B. Comment--LVADs as long-term cardiac replacement: Success but on what terms and at what cost? J Card Fail. 2002 Apr; 8(2):61-2. PMID: 12016627.
      View in: PubMed
    160. Cuffe MS, Califf RM, Adams KF, Benza R, Bourge R, Colucci WS, Massie B, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002 Mar 27; 287(12):1541-7. PMID: 11911756.
      View in: PubMed
    161. Massie B. Neurohormonal blockade in chronic heart failure. How much is enough? Can there be too much?. J Am Coll Cardiol. 2002 Jan 02; 39(1):79-82. PMID: 11755290.
      View in: PubMed
    162. Massie B. To Combat Hypertension, Increase Activity. Phys Sportsmed. 1992 May; 20(5):88-111. PMID: 29278177.
      View in: PubMed
    Barry's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _